Adam leads work in business development and translational research within the University of the Highlands and Islands School of Health. This includes stakeholder engagement, negotiating IP and licensing opportunities, and guiding University research towards commercially relevant outcomes, via products, services, spin-outs or start-ups.

After graduating from the University of Rochester, Dr Adam Giangreco completed a PhD in cell biology and molecular physiology at the University of Pittsburgh. He was then awarded two fellowships to relocate to the UK with Cancer Research UK. He subsequently ran a successful research lab at University College London, before his interest in research commercialisation saw him appointed lead biologist within the medical devices group at TTP, a technology development company based in Cambridge. Within this role, Adam worked with colleagues from diverse backgrounds to identify new business opportunities, design innovative projects, and implement new technologies. In April 2018, he joined the team at UHI.